CDH1 and breast cancer: Ward et al. [68] established a tamoxifen-resistant (TamR) breast cancer model, which exhibited mesenchymal properties with decreased E-cadherin expression and increased expression of fibronectin and ZEB1. Studies suggest that AEG-1 enhances the EMT of breast cancer, and also plays an important role in chemoresistance.